Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jun 7, 2010; 16(21): 2682-2688
Published online Jun 7, 2010. doi: 10.3748/wjg.v16.i21.2682
Table 1 Details of recipients and diagnostic indications (n = 182)
n (%)
Female25 (13.74)
Male157 (86.26)
Age (yr)
18-60173 (95.05)
60-699 (4.95)
Diagnostic indications
Liver cirrhosis74 (40.66)
Hepatitis B52 (28.57)
Hepatitis C5 (2.75)
Cholestasis5 (2.75)
Alcoholic4 (2.20)
Others8 (4.39)
Hepatic carcinoma77 (42.31)
FIF10 (5.49)
Acute-on-chronic hepatic failure9 (4.94)
Budd-Chiari[19]4 (2.20)
DI IBS4 (2.20)
Post-trauma hepatic failure1 (0.55)
Hepatic echinococcosis2 (1.10)
Polycystic liver1 (0.55)
MELD
1-1386 (47.25)
14-2463 (34.62)
≥ 2533 (18.13)
Table 2 Details of dual donors
No.Donor 1
Donor 2
GenderAge (yr)GraftGenderAge (yr)Graft
1F34LLF31LL
2F56RLM27Cadaveric LL
3F35RLM55LLS
4F29RLM29Cadaveric LL
5M42RLF29LL
6M58LLF34RL
71M45RLF26RL
8F34RLM35LL
9F20RLF39LLS
102F28RLF28RL
Table 3 Details of hepatic arteries (n = 192)
n (%)
RHA62 (32.29)
LHA20 (10.42)
PHA90 (46.88)
CHA14 (7.29)
Aberrant RHA12 (1.04)
AA4 (2.08)
Table 4 Management and outcome of HAT after A-A LDLT
CaseGenderAge (yr)GraftDiagnosis and management time post A-A LDLT (d)ManagementSurvival
1Male43RL1, 1RevascularizedAlive
21Male57RL + LLS7, 7RevascularizedAlive
3Male40RL3, 3MedicationsDead
4Female33RL46ObservationAlive